Covered recipient · General Payments record
STEVEN M LEPETICH
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018
$269.12
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $214.72 | 13 |
| Education | $54.40 | 3 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $74.60 | 4 |
| AMAG Pharmaceuticals, Inc. | $54.40 | 3 |
| Daiichi Sankyo Inc. | $35.43 | 2 |
| COVIDIEN LP | $35.11 | 3 |
| Minerva Surgical, Inc | $24.23 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.29 | 1 |
| Lupin Inc. | $14.74 | 1 |
| CooperSurgical, Inc. | $11.32 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $269.12 | 16 |
Payment records · PY2018 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $16.44 | 02/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | 570710987 | CMS |
| AbbVie, Inc. | $21.64 | 08/17/2018 | Food and Beverage | Undisputed | 01/23/2026 | 571184821 | CMS |
| AbbVie, Inc. | $20.53 | 09/05/2018 | Food and Beverage | Undisputed | 01/23/2026 | 571174887 | CMS |
| AbbVie, Inc. | $15.99 | 11/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | 571407707 | CMS |
| AMAG Pharmaceuticals, Inc. | $22.49 | 05/16/2018 | Education | Undisputed | 01/23/2026 | 559490665 | CMS |
| AMAG Pharmaceuticals, Inc. | $10.59 | 08/20/2018 | Education | Undisputed | 01/23/2026 | 559490671 | CMS |
| AMAG Pharmaceuticals, Inc. | $21.32 | 10/09/2018 | Education | Undisputed | 01/23/2026 | 559490675 | CMS |
| Boston Scientific Corporation | $19.29 | 03/27/2018 | Food and Beverage | Undisputed | 01/23/2026 | 548771357 | CMS |
| CooperSurgical, Inc. | $11.32 | 09/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | 605632457 | CMS |
| Covidien LP | $12.39 | 02/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 565058507 | CMS |
| Covidien LP | $11.77 | 05/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 565058513 | CMS |
| Covidien LP | $10.95 | 07/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | 565058525 | CMS |
| Daiichi Sankyo Inc. | $15.75 | 08/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 612589547 | CMS |
| Daiichi Sankyo Inc. | $19.68 | 10/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | 612628219 | CMS |
| Lupin Inc. | $14.74 | 08/29/2018 | Food and Beverage | Undisputed | 01/23/2026 | 605065167 | CMS |
| Minerva Surgical, Inc | $24.23 | 01/24/2018 | Food and Beverage | Undisputed | 01/23/2026 | 612292099 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.